| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |